Monday, October 26, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· January 2, 2018

Gentex to Demonstrate New Connected Car, Biometrics and Digital Rear Vision Technologies at CES 2018

View original at globenewswire.com
Gentex to Demonstrate New Connected Car, Biometrics and Digital Rear Vision Technologies at CES 2018 Gentex to highlight: HomeLink Connect™, an all-new car-to-home automation system that allows drivers to operate home automation devices from the vehicle’s touch screenThe latest automotive biometrics system that authent…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • This year Gentex will be demonstrating fully functional, vehicle-integrated versions of these same features, along with exciting new technology that is currently under development

    80% confidence
  • When you combine Visa's leadership in digital payments with Gentex's connected car features and in-vehicle displays, they can work together to help automakers implement unique and robust in-vehicle payments solutions

    80% confidence
  • By adding cloud-based wireless control to HomeLink's traditional RF functionality, the feature stands to remain the industry's most versatile, reliable, and comprehensive in-vehicle home automation system

    80% confidence
  • The driver's eyes are key to securing and customizing the in-vehicle, connected-car experience

    80% confidence
  • Gentex and Visa are working together to show the ways that their technology and in-vehicle payments can complement one another

    80% confidence
  • By knowing exactly who is behind the wheel, automakers can implement vehicle security, personalize the vehicle cabin, and secure access to cloud-based accounts, apps, and additional connected-car services

    80% confidence
  • Last year at CES, Gentex unveiled several new prototype technologies that garnered lots of attention from automakers

    80% confidence
  • HomeLink Connect opens the feature to new markets and new users by providing an ever-expanding number of use cases

    80% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Window: ESMO Data, the Ivonescimab PDUFA and Small-Cap Delistings
Mid-October to November 2026 is a dense catalyst period for clinical-stage biotech. Positive late-stage readouts (ALOFT-IPF, TELIGAN, MIUDELLA, the duvakitug extension) and the ESMO 2026 presentations lead up to the FDA's 14 November PDUFA date for the ivonescimab BLA. At the opposite end of the market, Spago Nanomedical is moving to delist from Nasdaq First North, which shows how hard it is for micro-cap developers to fund themselves. Value is concentrating in companies with late-stage data and near-term regulatory outcomes.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,500 source documents archived
Query this data → isubstrate.com